跳至主要内容
临床试验/NCT01013636
NCT01013636Unknown不适用

Epidemiology and Clinical Presentation of Human Anaplasmosis in Eastern France

University Hospital, Strasbourg, France12 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
12
主要终点
Risk factor, clinical and biological markers of infection for patients with Anaplasma antibody seroconversion

研究概览

简要总结

Anaplasmosis is a tick-borne transmitted infection. Its clinical expression include fever, cytopenia and hepatitis.This infection was initially described in United States. In Europe, its epidemiology is not well known. Some isolated cases have been diagnosed in several country, were the tick Ixodes ricinus is known to transmitted another infection :the Lyme borreliosis.The purpose of our study is to look systematically for Anaplasmosis, in patient living in Eastern France, and presenting with compatible clinical symptoms using a new diagnosis tool : PCR in blood samples. So we will have new data about epidemiology in our country and the clinical symptoms that are associated with Anaplasmosis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with at least one of following symptoms : fever or muscular pain or articular pain or respiratory signs or neurological signs or meningitis or erythema occurring during the three weeks after a tick bite-
  • patient with fever with at least one of following criteria : thrombocytopenia, leucopenia, hepatitis, without any other cause that can explain these abnormalities.
  • patient with tick-borne encephalitis, or primary stage Lyme borreliosis

排除标准

  • children less that 10 years
  • pregnancy
  • patients with an other diagnosis that can explain clinical symptoms or biological abnormalities
  • antibiotherapy with cyclins during the days before inclusion

结局指标

主要结局

Risk factor, clinical and biological markers of infection for patients with Anaplasma antibody seroconversion

时间窗: 6 weeks

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other

研究点 (12)

Loading locations...

相似试验